Stay updated with breaking news from Adamj Townsend. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Investment analysts at Wedbush dropped their FY2025 EPS estimates for Apellis Pharmaceuticals in a report released on Wednesday, April 17th. Wedbush analyst L. Chico now expects that the company will earn $2.23 per share for the year, down from their prior estimate of $2.24. Wedbush currently has […]
Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its target price lifted by JPMorgan Chase & Co. from $78.00 to $79.00 in a research note published on Wednesday morning, Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the stock. A number of other brokerages also recently issued reports on APLS. Robert W. […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Research analysts at HC Wainwright issued their Q1 2024 earnings per share estimates for Apellis Pharmaceuticals in a report issued on Friday, July 21st. HC Wainwright analyst D. Tsao anticipates that the company will post earnings per share of ($0.93) for the quarter. The consensus estimate for […]
Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Free Report) – Investment analysts at Wedbush increased their Q3 2023 earnings estimates for shares of Apellis Pharmaceuticals in a note issued to investors on Thursday, July 20th. Wedbush analyst L. Chico now forecasts that the company will post earnings per share of ($1.06) for the quarter, up from their […]
Apellis Pharmaceuticals (NASDAQ:APLS – Free Report) had its price objective boosted by Robert W. Baird from $105.00 to $115.00 in a report released on Monday morning, FlyOnTheWall reports. Several other research firms have also recently issued reports on APLS. Oppenheimer boosted their price objective on shares of Apellis Pharmaceuticals from $96.00 to $108.00 in a […]